Stem Cell - Wiki Article This article is about the cell type. For the medical therapy, see Stem cell treatment. Stem cells are biological cells found in all multicellular organisms, that can divide (through mitosis) and dif... Stem Cell - Wiki Article - wikiplays.org Original @ http All Information Derived from Wikipedia using Creative Commons License: en.wikipedia.org Author: Unknown Image URL: en.wikipedia.org ( This work is in the Public Domain. ) Author: Mike Jones Image URL: en.wikipedia.org ( Creative Commons ASA 3.0 ) Author: User:Wykis Image URL: en.wikipedia.org ( This work is in the Public Domain. ) Author: Mikael Hggstrm Image URL: en.wikipedia.org ( This work is in the Public Domain. ) Author: Cardiff University Image URL: en.wikipedia.org ( Creative Commons ASA 3.0 )From:WikiPlaysViews:0 0ratingsTime:34:29More inEducation More here: Stem Cell - Wiki Article - Video … Continue reading →

LAS VEGAS -- Dr. Ralph Conti and Alfred Sapse were found guilty on all counts in federal court Wednesday of defrauding patients out of more than $1 million in promising bogus experimental stem cell treatments. They faced charges for an alleged scheme to defraud people with incurable diseases with a so-called miracle stem cell cure that involved injections of placentas. Sapse, 86,recruited Conti, 51, a pediatrician, for the scheme.The problem entails his adult patients who prosecutors say were given intoxicating promises. The pledges included cures for multiple sclerosis, cerebral palsy and claims the handicapped could walk again. Instead, prosecutors say Conti delivered infected injections and unproven science. Conti and Sapse were accused of defrauding patients out of upwards of $1 million with a medical practice that injected people with stem cells from placentas. They faced 24 felony charges for the financial part of the fraud. Prosecutors say the money paid by the incurable patients went to Sapse's personal accounts and to pay for gambling. He hired Conti to do the injections on adults. Prosecutors say he did no follow-up with patients, tracked no data and flatly told one patient the so-called treatment wouldn't even work. He also allegedly injected cells … Continue reading →

ALAMEDA, Calif.--(BUSINESS WIRE)-- BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that Chief Executive Officer Michael D. West, Ph.D. will present at the World Stem Cell Summit 2012 in West Palm Beach, Florida on Tuesday, December 4, 2012. Dr. West will be presenting in the session on Developing Combination Products: Cells, Genes, and Devices at 1:30 pm EST which will include an update on product development, including Renevia, PanC-Dx, and OpRegen. The presentation will be made available on BioTime's website at http://www.biotimeinc.com. World Stem Cell Summit 2012 will be the 8th annual event produced by the Genetics Policy Institute (GPI), a non-profit organization. Planned by and for the stem cell and regenerative medicine community, the goal of the Summit is to accelerate the discovery and development of lifesaving cures and therapies. This year, panels will address advancing treatments for specific diseases and conditions including: cancer, diabetes, HIV/AIDS, cardiovascular disease, spinal cord injury, paralysis, multiple sclerosis, ALS, Parkinson's, eye diseases and others. About BioTime, Inc. BioTime, headquartered in Alameda, California, is a biotechnology company focused on regenerative medicine and blood plasma volume expanders. Its broad platform of stem … Continue reading →

NEWARK, Calif., Nov. 29, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (STEM) announced today that Ann Tsukamoto, Ph.D., Executive Vice President, Research and Development, will make a presentation on the Company's clinical development programs at the 2012 World Stem Cell Summit to be held December 3-5 at the Palm Beach County Convention Center, West Palm Beach, Florida. Dr. Tsukamoto is scheduled to speak during the Clinical Trial Update session to be held 10:30 a.m. to 12:00 p.m. Eastern Time on Tuesday, December 4. Dr. Tsukamoto also will be moderating a discussion on the topic "Unproven Stem Cell Therapies and Deceptive Claims: Hidden Dangers to Patients." This plenary discussion is scheduled to be held 9:00 to 10:00 a.m. Eastern Time on Tuesday, December 4. StemCells, Inc. is a Silver Sponsor of the 2012 World Stem Cell Summit, which is planned by and for the global stem cell and regenerative medicine community and is the largest interdisciplinary stem cell conference. The goal of the 2012 World Stem Cell Summit is to accelerate the discovery and development of lifesaving cures and therapies by bringing together a range of stakeholders to establish a supportive environment of regulation, legislation, financing, reimbursement and patient advocacy. StemCells, Inc. … Continue reading →

A panel at the Harvard Law School Wednesday discussed the ethical debate over the use of embryonic stem cells in the United States, focusing on the burgeoning controversy surrounding the role of stem cell therapy in medical tourism. Medical tourism, in which patients travel internationally to gain access to specific health care services, has become increasingly common, panelists said. They said that reasons for medical tourism range from basic hip replacement surgery to black market organ sales. As most stem cell therapies are not approved in the United States, numerous patients are going abroad to countries like China and Russia where treatment is legal. Panelist I. Glenn Cohen, an assistant professor at the Law School, said that it was probable that a Chinese stem cell facility performs several hundred thousand of these treatments yearly. He said that numerous celebrities, including football quarterback Peyton Manning, have reportedly traveled abroad to receive stem cell treatment not approved by the FDA. A number of facilities claim to use stem cells to cure a wide array of diseases. University of Alberta law professor Timothy Caulfield, another panelist, pointed out that a simple Google search leads potential patients to a plethora of websites which claim … Continue reading →

Stem cell banks could serve as a valuable resource for emerging treatments in the field of regenerative medicine, though challenges remain to making them a reality, according to a panel of international experts who gathered at UCSF for a stem cell conference last month. Funding for the development of stem cell lines for research has long been subject to debate, especially before President Barack Obama lifted a Bush-era ban on federal funding in 2009, but now scientists are discussing how to best meet the anticipated need for stem cells for medicine as well as research. Shinya Yamanaka, MD, PhD Stem cell treatments developed from adult cells rather than from embryonic tissue are expected to enter clinical trials for macular degeneration in Japan next year, and early successes in such trials aimed at replacing damaged tissues would be expected to drive demand for such stem cells upward. Worldwide, stem cell scientists in academia, government and the private sector are gauging strategies for moving forward with stem cell banks to meet expected demand. So far, countries have been taking different paths toward acquiring these resources, panelists said at an Oct. 25 discussion at the International Society for Stem Cell Research conference held … Continue reading →